Group 1 - The core point of the article is that Mogao Co., Ltd. held its 11th fourth board meeting on August 27, 2025, to review various proposals, including the revision of the annual work report management measures [1] - For the fiscal year 2024, the revenue composition of Mogao Co., Ltd. is as follows: biodegradable materials and products account for 33.76%, plastic products for 22.46%, pharmaceuticals for 20.45%, agriculture for 18.45%, and other businesses for 4.89% [1] - As of the report date, the market capitalization of Mogao Co., Ltd. is 2 billion yuan [1]

Core Viewpoint - Several wine companies, including Mogaos, are forecasting significant losses for the first half of the year, with Mogaos expected to incur losses of 25 to 37 million yuan, marking a substantial increase in losses compared to the previous year [1][8]. Group 1: Financial Performance - Mogaos' wine business has seen a declining share of total revenue, with wine accounting for only 18.45% of revenue in 2024, down from 83.54% in 2017 [2]. - The company has reported continuous losses over the past four years, with losses of approximately 98.7 million yuan in 2021, 111 million yuan in 2022, 41.4 million yuan in 2023, and projected losses of 25 to 37 million yuan for the first half of 2025 [8]. Group 2: Business Diversification and Challenges - Mogaos has shifted its focus to biodegradable materials, which now dominate its revenue, but this segment has also shown signs of losses since 2022 [4]. - The pharmaceutical segment has experienced a decline in production and sales prices, contributing to reduced profitability [4]. Group 3: Market Dependency and Distribution - Mogaos relies heavily on the Gansu provincial market for wine sales, with provincial revenue being 1.5 times that of external markets in 2023 [5]. - The number of distributors for Mogaos' wine has decreased, with 50 distributors lost despite 48 new additions, indicating a shrinking market presence [6][7]. Group 4: Regulatory and Market Environment - The company faces potential delisting risks if it fails to achieve a revenue of 300 million yuan in 2024, with negative net profits [8]. - Mogaos' chairman has been implicated in insider trading, which has negatively impacted market confidence, although the company claims it does not affect operations [8].

Core Viewpoint - Gansu Mogao Industrial Development Co., Ltd. reported a significant increase in revenue for 2024, driven by strong performance in its biodegradable materials and pharmaceutical segments, while facing a decline in its wine business [2][3]. Revenue Performance - The company achieved a total revenue of 328 million yuan in 2024, representing a year-on-year growth of 65.38% - After excluding non-core business income, the revenue was 312 million yuan, reflecting a growth of 78.98% [2]. Business Segment Analysis - The wine business generated revenue of 60.56 million yuan, a decrease of 17.41% year-on-year - The pharmaceutical segment saw revenue of 67.12 million yuan, an increase of 35.71% - The biodegradable materials and products segment reported revenue of 111 million yuan, marking a substantial growth of 114.56% - The new film bag business contributed 73.71 million yuan in revenue [2]. Strategic Initiatives - The company focused on the recovery of PBAT prices, optimizing production to maintain market share - It developed new products to extend the value chain, including fully biodegradable film formulations [2]. - Mogao continued to integrate internal resources by acquiring a 49% stake in Gansu Mogao Hongyuan Agricultural Technology Co., Ltd. at zero cost, enhancing its film production capabilities [3]. - The company increased sales efforts towards its controlling shareholder and its affiliates, securing a majority of film orders [3]. Future Outlook - Mogao plans to implement a dual-driven strategy of "wine + biodegradable materials" to enhance product quality and innovate marketing approaches - The company aims to capitalize on market opportunities in the environmental new materials sector, improving R&D capabilities and production stability [3].

Core Viewpoint - After three consecutive years of losses, Mogo Co. not only failed to turn a profit in 2024 but also saw its losses widen [1] Financial Performance - In 2024, Mogo Co. achieved revenue of approximately 329 million yuan, a year-on-year increase of 65.38% [1] - The net profit attributable to shareholders was approximately -52.08 million yuan, compared to a loss of 41.44 million yuan in the same period last year, indicating an expanded loss [1] Business Segment Analysis - Mogo's wine business, traditionally a representative of high-end Chinese wine, generated revenue of approximately 60.56 million yuan in 2024, a decline of 17.41% year-on-year, contributing less than 20% to total revenue [1][2] - The wine segment became the lowest revenue-generating business among Mogo's various operations in 2024 [2] - The decline in wine revenue was attributed to increased competition and insufficient consumer demand, exacerbated by the domestic liquor industry's pressure on the wine sector [3] - The biodegradable materials and products segment accounted for over 30% of total revenue, achieving approximately 110.81 million yuan in revenue, a significant increase of 114.56% year-on-year [3] - The pharmaceutical business generated approximately 67.12 million yuan in revenue, reflecting a year-on-year growth of 35.71% [3] Profitability Metrics - The gross margin for the wine business was 50.5% in 2024, a decrease of 5.91 percentage points compared to the previous year [6] - The pharmaceutical segment's gross margin was 48%, an increase of 14.2 percentage points year-on-year [6] - The gross margin for biodegradable materials and membrane products was negative [6] Q1 2025 Performance - In the first quarter of 2025, Mogo Co. reported revenue of 61.52 million yuan, a year-on-year decline of 24.08% [10] - The net profit attributable to shareholders was a loss of 10.01 million yuan, compared to a profit of 0.81 million yuan in the same period last year [10]